A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB. JAMA Psychiatry. 2017 Apr 1;74(4):399-405.
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Abdallah C.G., Sanacora G., Duman R.S., Krystal J.H. Annu. Rev. Med. 2015;66:509–523.
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A, Parides MK, Murrough JW, et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2014;71(6):681–688.
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Shiroma PR, Johns B, Kuskowski M, Wels J, Thuras P, Albott CS, Lim KO. Journal of Affective Disorders. 2014 Feb;155:123-9.
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
Carlos A. Zarate Jr, MD; Jaskaran B. Singh, MD; Paul J. Carlson, MD; et al. Arch Gen Psychiatry. 2006;63(8):856–864.
Antidepressant Effects of Ketamine in Depressed Patients
Robert M. Berman, Angela Cappiello, Amit Anand, Dan A. Oren, George R. Heninger, Dennis S. Charney, and John H. Krystal. Biol Psychiatry. 2000 Feb 15;47(4):351-4.
Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Pain Med. 2004 Sep;5(3):263-75.
Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.
Sheetal Patil, MD, Magdalena Anitescu, MD, PhD.Pain Medicine, Volume 13, Issue 2, February 2012, Pages 263–269.